MK-4618

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-4618, covering 2016-02-02 to 2016-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010) [Phase 1]